Loading
An 80-gene tissue test that sorts an early breast cancer into one of three biological types, used alongside MammaPrint.
Agendia describes BluePrint as "an 80-gene molecular subtyping test" that classifies tumours as luminal, HER2-type or basal-type, and states that it "is a laboratory-developed test" which "has not been cleared by the U.S. Food and Drug Administration (FDA) but has been CE-marked for use in Europe". In the development study 56 per cent of patients in the basal-type group and 50 per cent in the HER2-type group had a pathological complete response to neoadjuvant chemotherapy (Krijgsman 2012). Medicare's Palmetto MolDX article A53484 (effective 1 April 2026) states that there is insufficient evidence of clinical utility and that "the BluePrint test is a statutorily excluded test".
Expression of 80 genes in breast tumour tissue classifies the tumour as luminal-type, HER2-type or basal-type, usually reported alongside MammaPrint.
| Country | Reimbursement | List price | Assistance |
|---|---|---|---|
| United States | Not covered by Medicare: Palmetto MolDX article A53484 calls BluePrint a statutorily excluded test for breast cancer subtyping (effective 1 April 2026) | not disclosed | - |
List prices are manufacturer or Medicare figures where publicly disclosed; net prices after rebates are usually lower. Reimbursement changes; check the payer.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"BluePrint" OR ABSTRACT:"BluePrint" OR TITLE:"Agendia BluePrint" OR ABSTRACT:"Agendia BluePrint" OR TITLE:"BluePrint 80-gene" OR ABSTRACT:"BluePrint 80-gene") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about BluePrint, not a curated reading list.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares RNA sequencing & expression profiling and the tags test, rna.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/